You are here: Industry Insights > Clinical Trial

News List

NIH-sponsored trials evaluate monoclonal antibodies for Covid-19 treatment pharmaceutical-technology
December 18, 2020
The National Institutes of Health (NIH) in the US has announced the initiation of two Phase III clinical trials analysing investigational monoclonal antibodies for treating people hospitalised with moderate Covid-19.
NeuroTherapia Completes NTRX-07 Phase 1a Clinical Trial americanpharmaceuticalreview
December 18, 2020
NeuroTherapia announced the completion of its first-in-human study of NTRX-07. This study was a single ascending dose clinical trial carried out in healthy volunteers.
Therapeutic Solutions Announces Positive QuadraMune Clinical Trial Data americanpharmaceuticalreview
December 18, 2020
Therapeutics Solution International announced new data from its clinical trial demonstrating an almost doubling of immune cell activity in healthy volunteers which were ingesting QuadraMune™ daily for a week.
COVAXIN is well tolerated with no serious adverse events in Phase I trials expresspharma
December 18, 2020
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants across 11 hospitals.
AstroRx® shows promise in early phase amyotrophic lateral sclerosis trial europeanpharmaceuticalreview
December 17, 2020
Amyotrophic lateral sclerosis (ALS) patients treated with AstroRx® had a 45 percent reduction in their disease progression rate.
First Patient Dosed in Trial of Ultra-Concentrated Rapid Acting Insulin Candidate for Diabetes americanpharmaceuticalreview
December 17, 2020
Arecor Limited has announced dosing of the first patient in a Phase I clinical trial for its second clinical stage product, an ultra-concentrated rapid acting insulin, AT278.
Thermo Fisher Expands Clinical Supply Services in Europe contractpharma
December 16, 2020
The new sites will bring much-needed clinical supply chain continuity and specialized cold chain and cryogenic expertise across Europe and globally.
Universal influenza vaccine shows promise in early-phase clinical trial europeanpharmaceuticalreview
December 10, 2020
The chimeric hemagglutinin (HA)-based vaccine induced a strong, functional immune response that lasted at least 18 months.
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study prnasia
December 07, 2020
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncology, announced that the ...
BioNTech, Fosun Pharma initiate Covid-19 vaccine candidate trial in China pharmaceutical-technology
November 27, 2020
BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have initiated Phase II clinical trial of their lead mRNA Covid-19 vaccine candidate, BNT162b2, in Taizhou and Lianshui, Jiangsu Province, China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page